Therefore we suspect that improved GSIS upon GPR40 partial agonist treatment may meter fasting as well as post prandial hyperglycemia in diabetics, leading to a reduction in EGP and normalization of circulating glucose. Here, FFAR1 is linked to Hyperglycemia.